{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:07:19Z","timestamp":1776892039097,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2020\/39\/B\/NZ5\/00745"],"award-info":[{"award-number":["2020\/39\/B\/NZ5\/00745"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nano.2026.102902","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:30:03Z","timestamp":1768930203000},"page":"102902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes"],"prefix":"10.1016","volume":"72","author":[{"given":"Joanna","family":"Ciep\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Jelonek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Musia\u0142-Kulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Jaworska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Czapla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Drzyzga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Cicho\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybilla","family":"Matuszczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Pilny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jarosz-Biej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryszard","family":"Smolarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nano.2026.102902_bb0005","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1021\/acs.molpharmaceut.5c00215","article-title":"Comparison of micelles single- and dual-targeted with folic acid and biotin as the delivery system of docetaxel horizontal line the influence of the type and amount of the ligand on morphology, physicochemical properties, and cytotoxicity","volume":"22","author":"Jurczyk","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2026.102902_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173692","article-title":"Vascular disrupting agents in cancer therapy","volume":"891","author":"Smolarczyk","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.nano.2026.102902_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10238-024-01501-1","article-title":"Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies","volume":"24","author":"Ciepla","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.nano.2026.102902_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2020.05.032","article-title":"Hypoxia-responsive nanoparticles for tumor-targeted drug delivery","volume":"490","author":"Li","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2026.102902_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cbi.2019.04.034","article-title":"Azodyes as markers for tumor hypoxia imaging and therapy: an up-to-date review","volume":"307","author":"Kumari","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.nano.2026.102902_bb0030","article-title":"Role of hypoxia in the tumor microenvironment and targeted therapy","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2026.102902_bb0035","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.2147\/IJN.S526497","article-title":"Tumor microenvironment-responsive nanoparticles: promising cancer PTT carriers","volume":"20","author":"Sun","year":"2025","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.nano.2026.102902_bb0040","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8862","article-title":"Hypoxia studies in non-small cell lung cancer: pathogenesis and clinical implications (review)","volume":"53","author":"Zhou","year":"2025","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.nano.2026.102902_bb0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J Cancer Res Ther"},{"issue":"33","key":"10.1016\/j.nano.2026.102902_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034902","article-title":"Novel-fosfamide monotherapy or in combination with doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcoma: a pooled analysis of randomized clinical trials","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nano.2026.102902_bb0055","article-title":"Doxorubicin\/adriamycin monotherapy or plus ifosfamide in first-line treatment for advanced soft tissue sarcoma: a pooled analysis of randomized trials","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.nano.2026.102902_bb0060","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/cncr.32795","volume":"126","author":"D\u2019Ambrosio","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.nano.2026.102902_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.nano.2026.102902_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.nano.2026.102902_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(89)90306-2","article-title":"A simple equation for the description of solute release. III. Coupling of diffusion and relaxation","volume":"57","author":"Peppas","year":"1989","journal-title":"Int J Pharm"},{"issue":"35","key":"10.1016\/j.nano.2026.102902_bb0080","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1039\/D0PY00826E","article-title":"Azoreductase-triggered fluorescent nanoprobe synthesized by RAFT-mediated polymerization-induced self-assembly for drug release","volume":"11","author":"Zhou","year":"2020","journal-title":"Polym Chem"},{"issue":"3","key":"10.1016\/j.nano.2026.102902_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032914","article-title":"Optimization of the hemolysis assay for the assessment of cytotoxicity","volume":"24","author":"Saebo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.nano.2026.102902_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells14141057","article-title":"Influence of hypoxia on tumor heterogeneity, DNA repair, and cancer therapy: from molecular insights to therapeutic strategies","volume":"14","author":"Kunachowicz","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.nano.2026.102902_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.nano.2026.102902_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ma17020319","article-title":"Polymersomes as the next attractive generation of drug delivery systems: definition, synthesis and applications","volume":"17","author":"Fonseca","year":"2024","journal-title":"Materials (Basel)"},{"issue":"21","key":"10.1016\/j.nano.2026.102902_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/polym14214702","article-title":"Amphiphilic block copolymers: their structures, and self-assembly to polymeric micelles and polymersomes as drug delivery vehicles","volume":"14","author":"Kuperkar","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.nano.2026.102902_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.actbio.2022.03.054","article-title":"Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes","volume":"145","author":"McCright","year":"2022","journal-title":"Acta Biomater"},{"issue":"4","key":"10.1016\/j.nano.2026.102902_bb0115","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.nanolett.0c03756","article-title":"Brush conformation of polyethylene glycol determines the stealth effect of nanocarriers in the low protein adsorption regime","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett"},{"issue":"6","key":"10.1016\/j.nano.2026.102902_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/nano8060373","article-title":"Challenges for the self-assembly of poly(ethylene glycol)(\u2212)poly(lactic acid) (PEG-PLA) into polymersomes: beyond the theoretical paradigms","volume":"8","author":"Apolinario","year":"2018","journal-title":"Nanomaterials (Basel)"},{"issue":"2","key":"10.1016\/j.nano.2026.102902_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020485","article-title":"Promising role of polylactic acid as an ingenious biomaterial in scaffolds, drug delivery, tissue engineering, and medical implants: research developments, and prospective applications","volume":"28","author":"Ranakoti","year":"2023","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.nano.2026.102902_bb0130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"10.1016\/j.nano.2026.102902_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071540","article-title":"CoCl2-mimicked endothelial cell hypoxia induces nucleotide depletion and functional impairment that is reversed by nucleotide precursors","volume":"10","author":"Kutryb-Zajac","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.nano.2026.102902_bb0140","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4161\/cc.8.9.8306","article-title":"HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia","volume":"8","author":"Hackenbeck","year":"2009","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.nano.2026.102902_bb0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.nano.2026.102902_bb0150","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/bit.20086","article-title":"Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions","volume":"86","author":"Glicklis","year":"2004","journal-title":"Biotechnol Bioeng"},{"issue":"5","key":"10.1016\/j.nano.2026.102902_bb0155","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s13346-023-01310-1","article-title":"Evaluation of paclitaxel-loaded polymeric nanoparticles in 3D tumor model: impact of tumor stroma on penetration and efficacy","volume":"13","author":"Priwitaningrum","year":"2023","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.nano.2026.102902_bb0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biomaterials.2018.08.014","article-title":"Hypoxia-responsive block copolymer radiosensitizers as anticancer drug nanocarriers for enhanced chemoradiotherapy of bulky solid tumors","volume":"181","author":"Yin","year":"2018","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.nano.2026.102902_bb0165","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.7150\/thno.26225","article-title":"Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy","volume":"8","author":"Hua","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.nano.2026.102902_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12951-023-02062-3","article-title":"A multi-functional hypoxia\/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea","volume":"21","author":"Li","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"Pt 1","key":"10.1016\/j.nano.2026.102902_bb0175","article-title":"An oral bioactive chitosan-decorated doxorubicin nanoparticles\/bacteria bioconjugates enhance chemotherapy efficacy in an in-situ breast cancer model","volume":"267","author":"Li","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102902_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125362","article-title":"Construction of carboxymethyl chitosan-based nanoparticles of hypoxia response for co-loading doxorubicin and tanshinone IIA","volume":"244","author":"Lu","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102902_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106338","article-title":"Preparation of C6 cell membrane-coated doxorubicin conjugated manganese dioxide nanoparticles and its targeted therapy application in glioma","volume":"180","author":"Du","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102902_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111632","article-title":"Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy","volume":"201","author":"Xu","year":"2021","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.nano.2026.102902_bb0195","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.2147\/IJN.S522504","article-title":"Improved hypoxic microenvironment by nanoformulation for effective T cell therapy in mice model","volume":"20","author":"Feng","year":"2025","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.nano.2026.102902_bb0200","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.2147\/IJN.S535460","article-title":"Nanomaterials application for STING pathway-based tumor immunotherapy","volume":"20","author":"Zhao","year":"2025","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.nano.2026.102902_bb0205","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/IJN.S515893","article-title":"Nanoparticle-based strategies to enhance the efficacy of STING activators in cancer immunotherapy","volume":"20","author":"Qiao","year":"2025","journal-title":"Int J Nanomed"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:03:03Z","timestamp":1773277383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S1549963426000031"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102902","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102902"}}